Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities
Armetti, L.
Bollettino chimico farmaceutico 138(11): 596-598
1999
ISSN/ISBN: 0006-6648 PMID: 10765472 Document Number: 504090
Document emailed within 1 workday
Related Documents
Schacter, L.P.; Anderson, C.; Canetta, R.M.; Kelley, S.; Nicaise, C.; Onetto, N.; Rozencweig, M.; Smaldone, L.; Winograd, B. 1992: Drug discovery and development in the pharmaceutical industry Seminars in Oncology 19(6): 613-621Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Gialdroni Grassi, G.; Bianchi, L. 1995: Guidelines for the management of community-acquired pneumonia in adults. Italian Society of Pneumology. Italian Society of Respiratory Medicine. Italian Society of Chemotherapy Monaldi Archives for Chest Disease 50(1): 21-27
Braddock, M. 2003: Inflammatory Processes in Drug Discovery - SRI Conference. 22-23 September 2003, Philadelphia, PA, USA IDrugs: the investigational drugs journal 6(11): 1049-1052
Thirstrup, S.; Heisterberg, J. 2008: Children on the drug development map. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 170(12): 1039
de Smet, P.A. 1987: The drug data bank of the KNMP (Royal Dutch Society for the Promotion of Pharmacology) Nederlands Tijdschrift Voor Geneeskunde 131(40): 1759-1763
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Baldi, F.; Crotta, S.; Penagini, R. 1998: Guidelines for the diagnostic and therapeutic management of patients with gastro-oesophageal reflux disease. A position statement of The Italian Association of Hospital Gastroenterologists (AIGO), Italian Society of Gastrointestinal Endoscopy (SIED), and Italian Society of Gastroenterology (SIGE) Italian Journal of Gastroenterology and Hepatology 30(1): 107-112
Virdis, A.; Ghiadoni, L.; Taddei, S. 2014: Clinical management of drug-induced hypertension: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA) High Blood Pressure and Cardiovascular Prevention: the Official Journal of the Italian Society of Hypertension 21(1): 77-79
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
Urquhart, J. 1984: Pharmacological and therapeutic aspects of drug administration by rate-controlled drug delivery systems: steady-state pharmacology Bollettino Chimico Farmaceutico 123(4): 155-168
Lerch, C. 1994: Responsibility for patient education in drug therapy from the viewpoint of the drug industry Zeitschrift für Arztliche Fortbildung 88(12): 1055-1060
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
Savonitto, S.; Ambrosini, V.; Marzocchi, A.; Tolaro, S.; Petronio, A.S.; Galassi, A.R.; Bongo, A.S.; Gaglione, A.; Bolognese, L. 2005: Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 106-118